Pathways of purine ribonucleotide catabolism in Ehrlich ascites tumor cells in vitro.
D000225:Adenine / Q000096:biosynthesis / Q000378:metabolism; D000241:Adenosine / Q000096:biosynthesis; D000249:Adenosine Monophosphate / Q000378:metabolism; D000818:Animals; D002247:Carbon Isotopes; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism*; D002460:Cell Line; D006147:Guanine / Q000096:biosynthesis / Q000378:metabolism; D006150:Guanine Nucleotides / Q000378:metabolism; D006151:Guanosine / Q000096:biosynthesis; D007042:Hypoxanthines / Q000096:biosynthesis / Q000378:metabolism; D007288:Inosine / Q000096:biosynthesis; D007292:Inosine Nucleotides / Q000378:metabolism; D007700:Kinetics; D008954:Models, Biological; D009711:Nucleotides / Q000378:metabolism*; D012263:Ribonucleosides / Q000096:biosynthesis; D012265:Ribonucleotides / Q000378:metabolism; D014970:Xanthines / Q000096:biosynthesis
D002247:Carbon Isotopes; D006150:Guanine Nucleotides; D007042:Hypoxanthines; D007292:Inosine Nucleotides; D009711:Nucleotides; D012263:Ribonucleosides; D012265:Ribonucleotides; D014970:Xanthines; D006151:Guanosine; D000249:Adenosine Monophosphate; D007288:Inosine; D006147:Guanine; D000225:Adenine; D000241:Adenosine